Drugs / ASA
last change Nov 2011 re-read 9 days ago

ASA

Investigated by
AstraZeneca · POZEN

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01094483 Mar → May 2010 platelet aggregation, spontaneous AstraZeneca Completed Met primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as ASA “PN400 + ASA” NCT01094483 ↗
Action Inhibit “LDA-mediated platelet cyclooxygenase (COX)-1 inhibition.” PMID 22078153 ↗ Nov 2011